Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Graviola da Bahia is a Brazilian natural products company specializing in the cultivation and industrial processing of Annona muricata, commonly known as graviola or soursop. Based in the state of Bahia, the company operates a vertically integrated supply chain that encompasses sustainable farming, harvesting, and the production of frozen pulp, dried leaves, and concentrated extracts. Their products are primarily marketed within the nutraceutical and functional food sectors, catering to the growing demand for botanical supplements with high antioxidant and anti-inflammatory properties. The company serves as a key supplier of standardized botanical inputs for the health and wellness industry both in Brazil and internationally. While not a traditional pharmaceutical developer, Graviola da Bahia focuses on the commercialization of bioactive compounds like annonaceous acetogenins found in the fruit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Graviola da Bahia.